Keros Therapeutics (KROS) Return on Equity [ROE] (2020 - 2026)
Keros Therapeutics (KROS) reported Return on Equity [ROE] of -31.88% for Q2 2026, down 34.50 percentage points from 2.62% a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Keros Therapeutics posted Return on Equity [ROE] of 19.90%, up 61.36 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of +57.34 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -41.46% in FY2024 (+8.73 pp), -50.19% in FY2023 (-9.98 pp), -40.21% in FY2022 (-16.95 pp) and -23.27% in FY2021 (+14.18 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q4 2024.
- Year over year, Return on Equity [ROE] gained in six of the last seven quarters, with an average year-over-year change of +26.23 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2025 (a gain of 51.22 percentage points); the low point was Q2 2026 (a drop of 34.50 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | - |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 4.97% |
| 10 | Keros Therapeutics | 222.95 Mn | -1.71 Bn | - | -31.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.88% |
| Dec 31, 2025 | 17.29% |
| Sep 30, 2025 | 9.14% |
| Jun 30, 2025 | 2.62% |
| Mar 31, 2025 | 0.65% |
| Dec 31, 2024 | -33.93% |
| Sep 30, 2024 | -39.38% |
| Jun 30, 2024 | -40.72% |
| Mar 31, 2024 | -44.31% |
| Dec 31, 2023 | -54.12% |
| Sep 30, 2023 | -49.25% |
| Jun 30, 2023 | -39.17% |
| Mar 31, 2023 | -37.75% |
| Dec 31, 2022 | -40.38% |
| Sep 30, 2022 | -36.22% |
| Jun 30, 2022 | -36.20% |
| Mar 31, 2022 | -28.73% |
| Dec 31, 2021 | -25.45% |
| Sep 30, 2021 | -27.52% |
| Jun 30, 2021 | -22.40% |
API Access
Keros Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();